Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Oct 22.
Published in final edited form as: Chem Commun (Camb). 2011 Sep 5;47(38):10602–10604. doi: 10.1039/c1cc13409d

Reverse orthogonal strategy for oligosaccharide synthesis,,§

Kohki Fujikawa 1, N Vijaya Ganesh 1, Yih Horng Tan 1, Keith J Stine 1, Alexei V Demchenko 1,
PMCID: PMC3805137  NIHMSID: NIHMS406667  PMID: 21892457

Abstract

Herein, we report the invention of a novel expeditious concept for oligosaccharide synthesis. Unlike the classic orthogonal strategy based on leaving groups, the reverse approach is based on orthogonal protecting groups, herein p-methoxybenzyl and 4-pentenoyl, which allows for efficient oligosaccharide assembly in the reverse direction.


It is already appreciated that a chemical or enzymatic synthesis1 could lead to natural oligosaccharides or glycoconjugates for study of their composition,2 conformation,3 interaction with other molecules,4 and determining their biological roles.5 Also, only the synthetic approach can provide unnatural mimetics that are often of interest due to their therapeutic and diagnostic potential.6 However, even with significant progress in the recent years, chemical synthesis of oligosaccharides remains cumbersome.

According to the conventional (linear) oligosaccharide synthesis, disaccharides obtained as a result of the first glycosylation step are typically converted into the second-generation glycosyl acceptor via liberation of a specific hydroxyl. This requires the formal additional synthetic step that is often associated with isolation and purification of the glycosyl acceptor. The latter is then allowed to react with a glycosyl donor, resulting in the formation of a trisaccharide (Scheme 1a). The deprotection–glycosylation steps are then reiterated to yield larger saccharides. Because the reactive monosaccharide glycosyl donor is used at every step, the yields of glycosylations typically remain high.7 However, the requirement to perform additional deprotection steps between glycosylations is the major conceptual disadvantage of the conventional approach.

Scheme 1.

Scheme 1

(a) Conventional linear synthesis involving separate glycosylation and deprotection steps. (b) Ogawa’s leaving group-based orthogonal strategy. (c) New reverse orthogonal concept based on orthogonal protecting groups.

Many modern strategies that help to streamline oligosaccharide assembly by minimizing or even eliminating protecting/leaving group manipulations between coupling steps are based either on chemoselective or on selective activations of leaving groups.8 Amongst these, Ogawa’s orthogonal concept is arguably the most advantageous.9,10 This technique implies the use of two orthogonal leaving groups (LGa and LGb) and requires a pair of orthogonal activators: A (activates LGa selectively) and B (activates LGb, but not LGa, Scheme 1b). Theoretically, the orthogonal strategy allows for unlimited number of reiterations of leaving groups. In practice, however, the efficiency of glycosylations declines rapidly with the increase of the bulk of glycosyl donor: di(85%) →tri(72%) →tetra(66%).9 In our related study, STaz/SEt activation yielded the following decline in yields di(98%)→tri(93%)→tetra(77%)→penta(59%).11 Resultantly, this drawback precludes extending the orthogonal-like assembly and is often practical for the synthesis of relatively small oligosaccharides. 12,13

Herein we report a reverse orthogonal strategy that combines advantages of the linear (monosaccharide donor and high yields at each step) and orthogonal (no protecting group manipulations required) approaches. As opposed to the Ogawa’s orthogonal strategy based on orthogonal leaving group, we base our approach on the orthogonal protecting groups (PGa and PGb, Scheme 1c). This reverse approach would allow for oligosaccharide assembly in the opposite direction to that of the leaving group-based approaches. The oligosaccharide will be elongated in a similar manner to that of the linear approach, but the reverse orthogonal strategy will significantly shorten the synthesis by combining the deprotection and glycosylation steps.

The successful execution of the reverse strategy will require at least two orthogonal protecting groups (PGa and PGb) that will be removed during the glycosylation and in principle the couplings can be executed with only one type of a leaving group. A concept of orthogonal protecting groups is known, but it refers to orthogonally removable protecting groups;1417 for example, benzyl and benzoyl are orthogonal protecting groups. A glycosyl acceptor-based orthogonal approach has also been developed, but it the term “orthogonal” used therein refers to differentiation of carbonyl vs. hydroxyl glycosyl acceptors.18 A few concepts for protecting group-based glycosylations are known, and undoubtedly served as a powerful motivation for studies described here. Kochetkov demonstrated that triphenylmethyl (trityl) ethers can be glycosylated directly with orthoesters, thiocyanates or thioglycosides.19,20 Approaches involving “glycodesilylation” of TMS or TBDMS-protected glycosyl acceptors have also been developed.2124 None of these glycosylations, however, could be extended to the multi-step oligosaccharide synthesis due to the lack of the second (orthogonal) protecting group.

For the purpose of establishing a compatible pair of orthogonal protecting groups, we began screening a series of differently protected glycosyl acceptors. As the starting point, per-benzoylated S-ethyl glycoside 1a was chosen as the glycosyl donor. Initial coupling of 1a with 6-O-TBDMS-protected acceptor 2a in the presence of a powerful promoter system for thioglycoside activation NIS/Tf OH was very disappointing, and the resulting disaccharide 3a was isolated in a very modest yield of 11% (entry 1, Table 1). Our attempts to improve this result were unsuccessful, therefore, we began screening other temporary protecting groups. Encouragingly, Boc-protected glycosyl acceptor 2b could be glycosylated with 1a in the presence of SnCl4/EtSH, followed by the addition of NIS much more efficiently. However, still a rather average yield of 50% could be achieved (entry 2). Further screening of the compatible protecting groups showed that 6-O-p-methoxybenzyl (pMB) acceptor 2c could be glycosylated with 1a in the presence of either SnCl4/EtSH25 followed by the addition of NIS (entry 3), or TMSI,26 followed by the addition of NIS/Tf OH (entry 4).

Table 1.

Establishment of protecting groups and the reaction conditions for the reverse orthogonal strategy

graphic file with name nihms406667u1.jpg
Entry Donora Acceptor Promoterb Product (yield)
1 1a 2a NIS/TfOH 3a (11%)
2 1a 2b SnCl4/EtSH,c NIS 3a (50%)
3 1a 2c SnCl4/EtSH,c NIS 3a (>80%)d
4 1a 2c TMSI, NIS/TfOH 3a (>80%)d
5 1a 2c NIS/TfOH 3a (<5%)d
6 1ae 2d NIS/TfOH/H2Oc 3a (>80%)d
7 1be 2d NIS/TfOH/H2Oc 3b (81%)
8 1c 2c SnCl4/EtSH, NIS 3c (<5%)d,f
9 1d 2c TMSI/AgOTf 3c (85%)
a

In all preliminary reactions donor and acceptor were used in equimolar amounts.

b

All reactions were performed in the presence of molec. sieves (3 or 4 Å).

c

The use of water or EtSH (1 equiv.) was found to improve the yield.

d

Estimated by TLC.

e

Donor was added upon complete deprotection of the acceptor.

f

Pentenoyl group of the donor was removed instead.

In both reactions, disaccharide 3a was cleanly generated with yields exceeding 80%. Conversely, NIS/TfOH-promoted glycosylation of 2c with 1a was rather inefficient, and only traces of disaccharide 3a were obtained (entry 5). Further search of suitable protecting groups revealed that 6-O-pentenoyl (Pent) acceptor 2d can be efficiently glycosylated with 1a in the presence of NIS/Tf OH. Improved yield of 3a, exceeding 80% could be achieved if water (1.0 equiv.) was added to the reaction (entry 6). Although O-(pent-4-enoyl) moiety has been investigated as the anomeric leaving group2729 and as a precursor for the synthesis of sugar-based macrocycles,30,31 its use as a temporary protecting group of carbohydrates32 is still uncommon.

In our opinion, the latter two reactions created the basis for the first step of orthogonal activation: pMB is stable in the presence of NIS/TfOH as shown in entry 5, whereas pentenoyl can be easily removed followed by glycosylation of the liberated hydroxyl (entry 6). To prove the concept, we obtained 6-O-pMB glycosyl donor 1b and glycosidated it with glycosyl acceptor 2d equipped with pentenoyl. The highest yield of disaccharide 3b (81%, entry 7) was achieved if the donor 1b was used in excess or, alternatively, if it was added upon deprotection of 2d. Although the mechanistic rationale is still to be understood, the use of water (1 equiv.) was found necessary to maintain high yields of this reaction.

With the intention of determining the reaction conditions for the second-stage orthogonal activation, we obtained 6-Opentenoyl glycosyl donor 1c. Disappointingly its coupling with 6-O-pMB acceptor 2c in the presence of SnCl4/EtSH and NIS was inefficient due to the rapid hydrolysis of pentenoyl group (entry 8). This was resolved by using a similar building block 1d equipped with the SBox leaving group. Its glycosidation with the pMB acceptor 2c was carried out in the presence of TMSI and AgOTf and the resulting disaccharide 3c was obtained in 85% yield (entry 9).

Having established the entirely orthogonal activation conditions, we turned our attention to the synthesis of a simple oligosaccharide sequence via alternating reverse orthogonal activation steps. Herein, a slight excess of the glycosyl donor was used in each step. First, disaccharide 3b was obtained from 1b and 2d in 81% as depicted in Scheme 2. The disaccharide 3b was then glycosylated with SBox donor 1d equipped with an O-pentenoyl group. The resulting trisaccharide 4 was obtained in 82% yield and then reacted with 1b to afford tetrasaccharide 5 in 71% yield. Finally, tetrasaccharide 5 was coupled with 1d and the resulting pentasaccharide 6 was isolated in 75% yield.

Scheme 2.

Scheme 2

Four-step synthesis of pentasaccharide 6 via the reverse orthogonal strategy.

To expand the scope of the strategy developed we decided to investigate the glycosylation of secondary glycosyl acceptors. For this purpose we obtained glycosyl acceptors 7a and 7b equipped with 4-O-pentenoyl and 4-O-pMB groups respectively. Essentially the same reaction conditions developed earlier for glycosylation of primary glycosyl acceptors (Table 1) ensured successful glycosylation here as well. Thus, glycosylation of 7a with glycosyl donor 1b performed in the presence of NIS/Tf OH/H2O allowed 8a in 76% yield (Scheme 3). On the other hand, glycosylation of 7b with glycosyl donor 1d led to the formation of disaccharide 8b in 65% yield. Very similar outcomes were achieved in the presence of TMSI/AgOTf or TMSI/MeOTf as activators with the major by-product recovered being the corresponding 4-OH derivative of 7b.

Scheme 3.

Scheme 3

Preliminary investigation of secondary glycosyl acceptors 7a and 7b.

In conclusion, we have discovered a simple strategy that complements both conventional linear method and expeditious orthogonal strategy for oligosaccharide synthesis. The utility of the concept has been demonstrated by a rapid assembly of pentasaccharide 6. It should be noted that consistent yields in the range of 70–80% could be achieved regardless of the size of the glycosyl acceptor. The approach developed is nearly equally efficient for glycosylation of secondary glycosyl acceptors. It is expected that the reverse orthogonal strategy will be also beneficial for oligosaccharide assembly using polymer,33,34 fluorous,35,36 ionic liquid,37,38 and nanoporous gold39 supports.

Supplementary Material

Supporting information

Footnotes

§

This work was supported by awards from NIGMS (GM090254 and GM077170)

This article is part of the ChemComm ‘Glycochemistry and glycobiology’ web themed issue

Electronic supplementary information (ESI) available: Experimental procedures and characterization data for the synthesis of all new compounds. See DOI: 10.1039/c1cc13409d

Notes and references

  • 1.Muthana S, Cao H, Chen X. Curr Opin Chem Biol. 2009;13:573–581. doi: 10.1016/j.cbpa.2009.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Duus JO, Gotfredsen CH, Bock K. Chem Rev. 2000;100:4589. doi: 10.1021/cr990302n. [DOI] [PubMed] [Google Scholar]
  • 3.Wormald MR, Petrescu AJ, Pao YL, Glithero A, Elliott T, Dwek RA. Chem Rev. 2002;102:371–386. doi: 10.1021/cr990368i. [DOI] [PubMed] [Google Scholar]
  • 4.Seah H, Basu A. In: Encyclopedia of Chemical Biology. Begley T, editor. John Wiley & Sons; 2008. [Google Scholar]
  • 5.Varki A. Glycobiology. 1993;3:97–130. doi: 10.1093/glycob/3.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cipolla L, Arajo AC, Bini D, Gabrielli L, Russo L, Shaikh N. Expert Opin Drug Discovery. 2010;5:721–737. doi: 10.1517/17460441.2010.497811. [DOI] [PubMed] [Google Scholar]
  • 7.Love KR, Andrade RB, Seeberger PH. J Org Chem. 2001;66:8165–8176. doi: 10.1021/jo015987h. [DOI] [PubMed] [Google Scholar]
  • 8.Smoot JT, Demchenko AV. Adv Carbohydr Chem Biochem. 2009;62:161–250. doi: 10.1016/S0065-2318(09)00005-5. [DOI] [PubMed] [Google Scholar]
  • 9.Kanie O, Ito Y, Ogawa T. J Am Chem Soc. 1994;116:12073–12074. [Google Scholar]
  • 10.Ito Y, Kanie O, Ogawa T. Angew Chem, Int Ed Engl. 1996;35:2510–2512. [Google Scholar]
  • 11.Pornsuriyasak P, Demchenko AV. Chem–Eur J. 2006;12:6630–6646. doi: 10.1002/chem.200600262. [DOI] [PubMed] [Google Scholar]
  • 12.Vidadala SR, Thadke SA, Hotha S. J Org Chem. 2009;74:9233–9236. doi: 10.1021/jo901837z. [DOI] [PubMed] [Google Scholar]
  • 13.Kaeothip S, Pornsuriyasak P, Rath NP, Demchenko AV. Org Lett. 2009;11:799–802. doi: 10.1021/ol802740b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Debenham JS, Madsen R, Roberts C, Fraser-Reid B. J Am Chem Soc. 1995;117:3302–3303. [Google Scholar]
  • 15.Bowers SG, Coe DM, Boons GJ. J Org Chem. 1998;63:4570–4571. [Google Scholar]
  • 16.Wu X, Grathwohl M, Schmidt RR. Angew Chem, Int Ed. 2002;41:4489–4493. doi: 10.1002/1521-3773(20021202)41:23<4489::AID-ANIE4489>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  • 17.Prabhu A, Venot A, Boons GJ. Org Lett. 2003;5:4975–4978. doi: 10.1021/ol0359261. [DOI] [PubMed] [Google Scholar]
  • 18.Buchan ZA, Bader SJ, Montgomery J. Angew Chem, Int Ed. 2009;48:4840–4844. doi: 10.1002/anie.200901666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tsvetkov YE, Kitov PI, Backinowsky LV, Kochetkov NK. Tetrahedron Lett. 1993;34:7977–7980. [Google Scholar]
  • 20.Tsvetkov YE, Kitov PI, Backinowsky LV, Kochetkov NK. J Carbohydr Chem. 1996;15:1027–1050. [Google Scholar]
  • 21.Raghavan S, Kahne D. J Am Chem Soc. 1993;115:1580–1581. [Google Scholar]
  • 22.Ziegler T. J Prakt Chem. 1998;340:204–213. [Google Scholar]
  • 23.Boons GJ, Bowers S, Coe DM. Tetrahedron Lett. 1997;38:3773–3776. [Google Scholar]
  • 24.Zhu T, Boons GJ. Tetrahedron Lett. 1998;39:2187–2190. [Google Scholar]
  • 25.Yu W, Su M, Gao X, Yang Z, Jin Z. Tetrahedron Lett. 2000;41:4015–4017. [Google Scholar]
  • 26.Jung ME, Lyster MA. J Org Chem. 1977;42:3761–3764. [Google Scholar]
  • 27.Kunz H, Wernig P, Schultz M. Synlett. 1990:631–632. [Google Scholar]
  • 28.Lopez JC, Fraser-Reid B. J Chem Soc, Chem Commun. 1991:159–161. [Google Scholar]
  • 29.Choi TJ, Baek JY, Jeon HB, Kim KS. Tetrahedron Lett. 2006;47:9191–9194. [Google Scholar]
  • 30.Descotes G, Ramza J, Basset JM, Pagano S, Gentil E, Banoub J. Tetrahedron. 1996;52:10903–10920. [Google Scholar]
  • 31.Fyvie WS, Peczuh MW. J Org Chem. 2008;73:3626–3629. doi: 10.1021/jo800027y. [DOI] [PubMed] [Google Scholar]
  • 32.Lopez JC, Gomez AM, Valverde S, Fraser-Reid B. J Org Chem. 1995;60:3851–3858. [Google Scholar]
  • 33.Werz DB, Castagner B, Seeberger PH. J Am Chem Soc. 2007;129:2770–2771. doi: 10.1021/ja069218x. [DOI] [PubMed] [Google Scholar]
  • 34.Seeberger PH. Chem Soc Rev. 2008;37:19–28. doi: 10.1039/b511197h. [DOI] [PubMed] [Google Scholar]
  • 35.Carrel FR, Geyer K, Codée JDC, Seeberger PH. Org Lett. 2007;9:2285–2288. doi: 10.1021/ol0705503. [DOI] [PubMed] [Google Scholar]
  • 36.Jaipuri FA, Pohl NL. Org Biomol Chem. 2008;6:2686–2691. doi: 10.1039/b803451f. [DOI] [PubMed] [Google Scholar]
  • 37.Yerneni CK, Pathak V, Pathak AK. J Org Chem. 2009;74:6307–6310. doi: 10.1021/jo901169u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tran AT, Burden R, Racys DT, Galan MC. Chem Commun. 2011;47:4526–4528. doi: 10.1039/c0cc05580h. [DOI] [PubMed] [Google Scholar]
  • 39.Pornsuriyasak P, Ranade SC, Li A, Parlato MC, Sims CR, Shulga OV, Stine KJ, Demchenko AV. Chem Commun. 2009:1834–1836. doi: 10.1039/b817684a. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting information

RESOURCES